Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

June 18, 2024 |  

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life sciences companies and accelerating patient access to optimal care.

David Miller at ITN studio talking of real world evidence, HEOR, and market access

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the participation of its CEO David W. Miller in an ITN Business program on advancing healthcare. The program highlights the company’s Flexible Integrated Team (FIT) engagement model and provides insights into how such innovative approaches and advanced technology are boosting efficiencies and accelerating patient access to optimal care.

David W. Miller’s interview by leading broadcaster Alice Beer will be showcased in Advancing Healthcare, set to premiere on 12 and 13 June 2024 at the NHS ConfedExpo in Manchester, UK. This insightful program delves into the future of healthcare through the lens of innovation, preventative thinking, data-driven health solutions, and collaborative efforts. Other leading industry figures featured include NHS Confederation CEO Matthew Taylor, NHS Supply Chain CEO Andrew New, and, in an extended edition from July, Susan Rienow, President of the Association of the British Pharmaceutical Industry (ABPI). The program, which features key industry and news-style reports along with sponsored editorial profiles, will showcase Genesis Research Group’s innovative approach to agile, tech-enabled research partnerships and both its stakeholder insight platform, RPR, and its AI-powered evidence synthesis services.

David W. Miller, Chief Executive Officer of Genesis Research Group, said: “We are excited to have been invited to represent the essential work of research organizations, and to show how Genesis Research Group continues to innovate differently through our agile FIT engagement model and tech-enabled solutions. The program is an excellent platform on which to highlight our commitment to integrating innovation, stakeholder insights, and scientifically rigorous expertise to better inform decision-making and improve patient outcomes.”

You can watch the program on Genesis Research Group’s website at: www.genesisrg.com/ITN

This content was provided by Genesis Research Group

Company Details

Genesis Research Group logo

Genesis Research Group

Email
Website

 Latest Content from  Genesis Research Group 

MFN Pricing Is Moving Fast – Here’s What Matters

With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — and yes, it's a lot to digest. In a new...

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...

Tim Wright Updates ISPOR Europe MFN Pricing Presentation in New Interview

At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright's HEOR Theater presentation 'MFN Pricing: More Fun to Navigate – A European Roadmap to Success,' with potentially...

Genesis Research Group contributes strong scientific program to ISPOR Europe and warmly invites visitors to booth 212

Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific program that includes an HEOR Theater session, contributions to 10...

ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs

On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

Genesis Research Group Appoints Tim Wright as Executive Vice President, Access and Pricing

Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Tim Wright as Executive Vice...

Navigating US market access analytics: A conversation with Ki Park

In the rapidly evolving landscape of healthcare and pharmaceutical market access, data analytics has become a critical component for making informed decisions. We sat down with Ki Park, our Vice...

Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.

In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...

Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...